NASDAQ:ADMS
Delisted
Adamas Pharmaceuticals Stock News
$8.22
+0 (+0%)
At Close: May 27, 2022
EMERYVILLE, Calif., July 15, 2020 -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) a company dedicated to developing and delivering medicines that make a meaningful difference to.
Adamas Announces New Employment Inducement Grant
08:05pm, Friday, 10'th Jul 2020
EMERYVILLE, Calif., July 10, 2020 -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company’s board of directors granted.
HCR Partners Announces Two New Appointments to Senior Advisor Board
12:00am, Tuesday, 07'th Jul 2020
HCR Partners Announces Two New Appointments to Senior Advisor Board
Analysts' Top Healthcare Picks: Bristol Myers (BMY), Viking Therapeutics (VKTX) - Markets
03:58pm, Thursday, 02'nd Jul 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Bristol Myers
Aridis Pharmaceuticals (ARDS) Gets a Buy Rating from Northland Securities - Markets
01:21pm, Monday, 22'nd Jun 2020
In a report released today, Carl Byrnes from Northland Securities maintained a Buy rating on Aridis Pharmaceuticals (ARDS – Research
Nabriva (NBRV) Gets a Buy Rating from Northland Securities - Markets
11:03am, Monday, 22'nd Jun 2020
Northland Securities analyst Carl Byrnes maintained a Buy rating on Nabriva (NBRV – Research Report) today and set a price
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Heron Therapeutics
Xeris Positive Data, And Other News: The Good, Bad And Ugly Of Biopharma
10:09am, Saturday, 20'th Jun 2020
Xeris Pharmaceuticals reports positive topline data for insulin trial. Eloxx restarts cystic fibrosis study. Adamas Pharmaceuticals reports disappointing data f
The Daily Biotech Pulse: Eloxx Resumes Cystic Fibrosis Study, Rexahn's Reverse Merger, Ultragenyx, Epizyme Await FDA Decisions
12:34pm, Thursday, 18'th Jun 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 17) * Adverum Biotechnologies Inc (NASDAQ: ADVM) * Affim
Adamas provides program update for ADS-5102 for multiple sclerosis patients with walking impairment
08:01pm, Wednesday, 17'th Jun 2020
Adamas Pharmaceuticals, Inc. (ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced the compl
Northland Securities Reaffirms Their Buy Rating on vTv Therapeutics (VTVT) - Markets
10:56am, Monday, 15'th Jun 2020
In a report released today, Carl Byrnes from Northland Securities maintained a Buy rating on vTv Therapeutics (VTVT – Research
Analysts have been eager to weigh in on the Healthcare sector with new ratings on NuVasive (NUVA – Research Report),
Acadian Asset Management LLC Takes Position in Adamas Pharmaceuticals Inc (NASDAQ:ADMS)
05:18am, Wednesday, 10'th Jun 2020
Acadian Asset Management LLC purchased a new stake in Adamas Pharmaceuticals Inc (NASDAQ:ADMS) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institu
